ND630 controls ACACA and lipid reprogramming in prostate cancer by regulating the expression of circKIF18B_003

Yu-Peng Wu1,2, Wen-Cai Zheng1,2, Qi Huang1,2

  • 1Department of Urology, Urology Research Institute, The First Affiliated Hospital, Fujian Medical University, 20 Chazhong Road, Fuzhou, 350005, China.

PubMed
Abstract

Insights

The drug ND630 regulates lipid metabolism and ACACA expression in prostate cancer by targeting circKIF18B_003. This study reveals circKIF18B_003 as a potential therapeutic target for prostate cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • ND630 is a novel molecule targeting ACACA and lipid metabolism, but its role in prostate cancer is unknown.
  • KIF18B is an oncogene crucial for prostate cancer progression, with its derived circRNA, circKIF18B_003, overexpressed in tumors.
  • This study investigates ND630's effect on prostate cancer via circKIF18B_003 regulation of ACACA and lipid reprogramming.

Purpose of the Study:

  • To determine if ND630 controls ACACA and lipid reprogramming in prostate cancer.
  • To investigate the role of circKIF18B_003 in prostate cancer progression.
  • To elucidate the regulatory mechanism of ND630 on circKIF18B_003.

Main Methods:

  • Quantitative real-time PCR (RT-qPCR) for circKIF18B_003 expression analysis.
  • Cellular assays (CCK-8, colony formation, wound healing, Transwell) and xenograft models to assess circKIF18B_003 function.
  • RNA immunoprecipitation (RIP), RNA pull down, and luciferase reporter assays to explore molecular mechanisms, including circKIF18B_003 sponging of miR-370-3p.

Main Results:

  • circKIF18B_003 overexpression in prostate cancer tissues correlates with poor patient survival.
  • Upregulation of circKIF18B_003 enhances prostate cancer cell proliferation, migration, and invasion.
  • circKIF18B_003 acts as a sponge for miR-370-3p, increasing ACACA expression and promoting malignant phenotypes; this effect is reversed by ACACA downregulation.
  • ND630 combined with docetaxel significantly reduced tumor growth, indicating a role in lipid metabolism regulation.

Conclusions:

  • ND630 regulates ACACA and lipid reprogramming in prostate cancer by modulating circKIF18B_003 expression.
  • ND630 and circKIF18B_003 represent a promising novel therapeutic target for prostate cancer.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.4K